APA (7th ed.) Citation

Herishanu, Y., Gibellini, F., Njuguna, N., Hazan-Halevy, I., Farooqui, M., Bern, S., . . . Wiestner, A. (2011). Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1. Leukemia & Lymphoma, 52(9), 1758. https://doi.org/10.3109/10428194.2011.569962

Chicago Style (17th ed.) Citation

Herishanu, Yair, et al. "Activation of CD44, a Receptor for Extracellular Matrix Components, Protects Chronic Lymphocytic Leukemia Cells from Spontaneous and Drug Induced Apoptosis Through MCL-1." Leukemia & Lymphoma 52, no. 9 (2011): 1758. https://doi.org/10.3109/10428194.2011.569962.

MLA (9th ed.) Citation

Herishanu, Yair, et al. "Activation of CD44, a Receptor for Extracellular Matrix Components, Protects Chronic Lymphocytic Leukemia Cells from Spontaneous and Drug Induced Apoptosis Through MCL-1." Leukemia & Lymphoma, vol. 52, no. 9, 2011, p. 1758, https://doi.org/10.3109/10428194.2011.569962.